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Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease among children 
characterized by fat deposits on the liver.  Given that NAFLD develops in obese children, 
with childhood obesity becoming more prevalent, NAFLD is also becoming more 
common in children.  NAFLD may lead to non-alcoholic steatohepatitis, cirrhosis of the 
liver, and liver failure.  The primary treatment for NAFLD is physical activity and weight 
loss, however non-compliance issues make this treatment unreliable.  Currently research 
is focusing on using vitamin E treatment to counter the oxidative stress that promotes 
NAFLD.   The objective of this systematic review was to analyze the efficiency of 
vitamin E treatment for obesity related liver disease.  Medline, Health Source, and 
Science Direct searches were conducted using the search terms “NAFLD, NASH, and 
vitamin E treatment.” Inclusion criteria included human clinical trials, published within 
the last 12 years, involving participants who suffered from obesity-related liver disease.  
Exclusion criteria included non-human trials, non-English publications, and study 
duration less than three-months.  Of the six studies examined (four randomized controlled 
trials, 2 non-randomized controlled trials) four showed normalization or improvement of 
aminotransferase levels with adherence to vitamin E supplement treatment: one study 
found that weight loss with or without exercise as treatment had comparative 
improvement to treatment with vitamin E alone; and one found vitamin E to have no 
significant additional improvement to alanine aminotransferase levels with weight loss. 
With further clinical trials, vitamin E supplementation may be a recommended treatment 
method for obese children when weight loss is unattainable. 
